{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:03:43Z","timestamp":1762340623729,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.hlc.2012.12.011","type":"journal-article","created":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T19:04:13Z","timestamp":1362078253000},"page":"523-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of a Policy of Selective Drug-eluting Stent Implantation for Patients at High Risk of Restenosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Ibrahim M.","family":"Shugman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan","family":"Idris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna Kishor","family":"Kadappu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Rajaratnam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidney","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig P.","family":"Juergens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John K.","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2012.12.011_bib0005","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease Stent Restenosis Study Investigators","volume":"331","author":"Fischman","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2012.12.011_bib0010","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2012.12.011_bib0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2012.12.011_bib0020","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2012.12.011_bib0025","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/CIRCULATIONAHA.108.826479","article-title":"Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies","volume":"119","author":"Kirtane","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2012.12.011_bib0030","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijcard.2008.06.046","article-title":"Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry","volume":"130","author":"Yan","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2012.12.011_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2012.01.014","article-title":"Safety and efficacy of rescue angioplasty for ST-elevation myocardial infarction with high utilization rates of glycoprotein IIb\/IIIa inhibitors","volume":"163","author":"Shugman","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.hlc.2012.12.011_bib0040","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jacc.2010.08.608","article-title":"Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial","volume":"56","author":"Stone","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2012.12.011_bib0045","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.110.978593","article-title":"Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry","volume":"124","author":"Venkitachalam","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2012.12.011_bib0050","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2012.12.011_bib0055","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.105.594952","article-title":"Propensity scores in cardiovascular research","volume":"115","author":"D\u2019Agostino","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2012.12.011_bib0060","unstructured":"New South Wales Health. Greater Metropolitan Clinical Taskforce (GMCT). Clinical guidelines for the use of drug eluting coronary artery stents in Public Hospitals in NSW, <http:\/\/www.health.nsw.gov.au\/resources\/gmct\/cardiac\/drug_eluting_stents_pdf.asp> [accessed 13.01.11]."},{"key":"10.1016\/j.hlc.2012.12.011_bib0065","unstructured":"National Institute for Health and Clinical Excellence. TA152 coronary artery disease\u2014drug-eluting stents: guidance, <http:\/\/www.nice.org.uk\/Guidance\/TA152\/Guidance\/pdf\/English> [accessed 29.12.10]."},{"key":"10.1016\/j.hlc.2012.12.011_bib0070","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa071076","article-title":"Effectiveness and safety of drug-eluting stents in Ontario","volume":"357","author":"Tu","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2012.12.011_bib0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5694\/j.1326-5377.2008.tb02113.x","article-title":"Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registry","volume":"189","author":"Ajani","year":"2008","journal-title":"Med J Aust"},{"key":"10.1016\/j.hlc.2012.12.011_bib0080","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/eurheartj\/ehr479","article-title":"Lower risk of stent thrombosis and restenosis with unrestricted use of \u2018new-generation\u2019 drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)","volume":"33","author":"Sarno","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2012.12.011_bib0085","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/eurheartj\/ehl490","article-title":"Targeted stent use in clinical practice based on evidence from the BAsel Stent Cost Effectiveness Trial (BASKET)","volume":"28","author":"Brunner-La Rocca","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2012.12.011_bib0090","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(07)61660-2","article-title":"Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitats Trial (BASKET): an 18-month analysis","volume":"370","author":"Brunner-La Rocca","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2012.12.011_bib0095","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.amjcard.2006.09.105","article-title":"Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (\u22653.5mm) coronary arteries","volume":"99","author":"Steinberg","year":"2007","journal-title":"Am J Cardiol"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950612014400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950612014400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T17:58:39Z","timestamp":1761415119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950612014400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1443950612014400"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2012.12.011","relation":{},"ISSN":["1443-9506"],"issn-type":[{"type":"print","value":"1443-9506"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of a Policy of Selective Drug-eluting Stent Implantation for Patients at High Risk of Restenosis","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2012.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}